LAVA-1207
lava therapeutics
['crpc', 'gu ', '$lvtx', 'lava therap']
$lvtx lava therapeutics announces initial data from the ongoing phase 1/2a clinical trial of lava-1207 in therapy refractory mcrpc at the 2023 asco gu symposium #clinicaltrial
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i